The US market for cardiac rhythm management (CRM) devices is expected to grow by approximately $1.1 billion at a compound annual growth rate (CAGR) of 2.9% over the next five years; diagnostic CRM products are forecast to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.
Two of the fastest growing areas of the CRM products market, electrophysiology (EP) and cardiac ablation devices, are being driven by an expansion in the use of ablation techniques to...